Showing 6891-6900 of 10547 results for "".
- Hispanic and Black Children More Likely to Miss School Due to Eczema Than White Childrenhttps://practicaldermatology.com/news/hispanic-and-black-children-more-likely-to-miss-school-due-to-eczema-than-white-children/2460036/Hispanic and black children are more likely than white children to miss school due to chronic eczema, a new study in JAMA Dermatology shows. Researchers from the Perelman School of Medicine at the University of Pennsylva
- Pilot Study: ESWT Improves Wound Healing Before Surgeryhttps://practicaldermatology.com/news/pilot-study-eswt-improves-wound-healing-before-surgery/2460032/Extracorporeal shockwaves (ESWT) initiated within the operation field prior to surgery may improve wound healing and minimize scar formation, according to a pilot study in Lasers in Surgery and Medicine (LSM). The
- Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIAhttps://practicaldermatology.com/news/nestle-enters-into-negotiations-to-sell-nestle-skin-health-to-consortium-led-by-eqt-and-adia/2460031/Nestlé has entered into exclusive negotiations with a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for the sale of Nestlé Skin Health for a value of CHF 10.2 billion. Nestlé Skin Health
- Skin Cancer Patients Prioritize Cosmetic Outcomes Over Costhttps://practicaldermatology.com/news/skin-cancer-patients-prioritize-cosmetic-outcomes-over-cost/2460030/Skin cancer patients who require surgery on their faces are willing to pay more for a smaller scar, according to a new study in the Journal of the American Academy of Dermatology. Researchers conducted a
- ISDIN Teams Up with The Claire Marie Foundation And The Ulman Foundation For Skin Cancer Awareness Monthhttps://practicaldermatology.com/news/isdin-teams-up-with-the-claire-marie-foundation-and-the-ulman-foundation-for-skin-cancer-awareness-month-1/2460027/Spain-based skincare company ISDIN is partnering with the Claire Marie Foundation and the Ulman Foundation in honor of Skin Cancer Awareness Month. For every Eryfotona Actinica Ultralight Emulsion SPF 50+ sunscreen sold during the month of May,
- Obagi Launches SKINCLUSION Initiative to Celebrate Diversity with Brand Ambassador Priyanka Chopra Jonashttps://practicaldermatology.com/news/obagi-launches-skinclusion-initiative-to-celebrate-diversity-with-brand-ambassador-and-priyanka-chopra-jonas/2460026/Obagi kicked off its SKINCLUSION initiative, designed to elevate the global dialogue about diversity and how we can all make conscious choices to see the beauty in all of our differences, with an event in New York City introducing Priyanka Chopra Jonas as its SKINCLUSION ambassador. Priyanka, an
- Sensus Healthcare Awarded Brachytherapy Products Agreement with Premierhttps://practicaldermatology.com/news/sensus-healthcare-awarded-brachytherapy-products-agreement-with-premier/2460025/Sensus Healthcare, Inc.has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Sensus’ SRT-100
- Abeona Therapeutics to Present EB-101 Data at Society for Investigative Dermatology Annual Meetinghttps://practicaldermatology.com/news/abeona-therapeutics-to-present-eb-101-data-at-society-for-investigative-dermatology-annual-meeting/2460024/Long-term follow up data from a completed Phase 1/2 study evaluating EB-101 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) will be presented at the 77th Annual Meeting of the Society for Investigative Dermatology (SID) in Chicago. The data will be presented by Stanfor
- Aesthetic Innovations Summit Coming to New Orleanshttps://practicaldermatology.com/news/aesthetic-innovations-summit-coming-to-new-orleans/2460022/Coming off an impressive inaugural meeting in 2018, the second annual Aesthetics Innovation Summit will unite over 300 of the most influential corporate, capital, and clinical leaders in New Orleans to collaborate on the development and adoption of new aesthetic treatments and technologies.
- Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for NMSC Patients Treated with Superficial Radiation Therapyhttps://practicaldermatology.com/news/five-year-retrospective-study-shows-989-percent-cure-rate-for-nmsc-patients-treated-with-superficial-radiation-therapy/2460013/Sensus Healthcare, Inc. shared topline results from a five-year retrospective study of non-melanoma ski